Imophoron

Bristol, United Kingdom

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Jul 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Imophoron's investors?

Imophoron's investors include Octopus Ventures, Global Brain Corporation, SCVC, Jonathan Milner.

Where is Imophoron headquartered?

Imophoron is headquartered in Bristol, United Kingdom.

What does Imophoron do?

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

What stage is Imophoron at?

Imophoron is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 7, 2023.

MLA

"Imophoron — Funding & Investors." VCBacked, July 7, 2023, https://www.vcbacked.co/company/imophoron. Accessed July 2, 2026.

APA

VCBacked. (2023). Imophoron — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/imophoron

Wikipedia (cite web)

{{cite web |title=Imophoron — Funding & Investors |url=https://www.vcbacked.co/company/imophoron |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 7, 2023.